Alliance Pharma PLC (ISE:APH)

Alliance Pharma PLC (ISE:APH)

Share Price
69.40 p
0.4 (0.58 %)
Market Cap
£360.29 m
Proactive Investors - Run By Investors For Investors

Alliance Pharma PLC RNS Release

Block Listing Six Monthly Return

RNS Number : 7615L
Alliance Pharma PLC
31 December 2018

31 January 2018




("Alliance" or the "Group")


Block Listing Six Monthly Return



Name of applicant:


Names of schemes:

a)   The Alliance Pharma plc Approved Share Option Plan 2005

b)   The Alliance Pharma plc Share Option Plan 2006

c)   The Alliance Pharma plc Company Share Option Plan 2015

Period of return:


28 June 2018


28 December 2018


Number of securities originally admitted at date of admission:

25,000,000 ordinary shares of 1p each

28 June 2017

Balance of unallotted securities under schemes from previous return:

a)   1,466,103

b)   17,416,041

c)   2,795,812

Plus:  The amount by which the block schemes have been increased since the date of the last return (if any increase has been applied for):

a)   Nil

b)   Nil

c)   Nil

Less:  Number of securities issued/allotted under schemes during period:

a)   374,837

b)   2,070,353

c)   745,890

Equals:  Balance under schemes not yet issued/allotted at end of period:

a)   1,091,266

b)   15,345,688

c)   2,049,922


Name of contact:

Chris Chrysanthou, Company Secretary

Telephone number of contact:

Tel. +44 (0)1249 705166


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

Alliance Pharma PLC Timeline

January 21 2019
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use